The Sleep Disorders Channel is supported through educational grants from Alkermes and Takeda.
VJNeurology is an independent medical education platform. Channel supporters have no influence over the production of content.
World Sleep 2022 | Risk prediction and treatment options in RLS
Evi Holzknecht, MD, Medical University of Innsbruck, Innsbruck, Austria, discusses the main challenges in risk prediction, treatment response, and risk of developing augmentation in restless legs syndrome (RLS) and highlights the importance of multifactorial risk assessment in the diagnosis and treatment of RLS. Dr Holzknecht explains her views on the potential for precision medicine – it will allow an earlier diagnosis of RLS, meaning patients can start adequate treatment faster. This interview was recorded at the World Sleep Congress 2022 in Rome, Italy.
